All DVT · orthopaedic (spinal)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Infection (up to 90 days) · orthopaedic (spinal)
Cell salvage showed no clear difference in infection (up to 90 days) compared with no cell salvage (low certainty).
1 finding from 1 review
MI (up to 90 days) ‐ not reported · orthopaedic (spinal)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stroke · orthopaedic (spinal)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (up to 90 days) · orthopaedic (mixed)
It is very uncertain whether cell salvage changes mortality (up to 90 days) compared with no cell salvage (very low certainty).
1 finding from 1 review
MI (up to 90 days) ‐ not reported · cancer surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Deep vein thrombosis · orthopaedic (mixed)
Cell salvage showed no clear difference in DVT (up to 90 days) compared with no cell salvage (low certainty).
1 finding from 1 review
Infection (up to 90 days) · orthopaedic (mixed)
It is very uncertain whether cell salvage changes infection (up to 90 days) compared with no cell salvage (very low certainty).
1 finding from 1 review
MI (up to 90 days) · orthopaedic (mixed)
It is very uncertain whether cell salvage changes MI (up to 90 days) compared with no cell salvage (very low certainty).
1 finding from 1 review
Stroke · orthopaedic (mixed)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stroke · cancer surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disease control (healing of skin lesions) at day 21 · bullous pemphigoid
Clobetasol propionate cream probably leads to higher disease control (healing of skin lesions) at day 21 compared with oral prednisone (moderate certainty).
1 finding from 1 review
Adverse events: severe complications at day 21 · bullous pemphigoid
Clobetasol propionate cream may leads to lower adverse events: severe complications at day 21 compared with oral prednisone (low certainty).
1 finding from 1 review
Return to normal activities (days) · patients with benign gynaecological disease
1 finding from 1 review
Return to normal activities (days) · patients with benign gynaecological disease
1 finding from 1 review
Return to normal activities (days) · patients with benign gynaecological disease
1 finding from 1 review
Return to normal activities (days) · patients with benign gynaecological disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Return to normal activities (days) · patients with benign gynaecological disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Return to normal activities (days) · patients with benign gynaecological disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Return to normal activities (days) · patients with benign gynaecological disease
1 finding from 1 review